Tetrandrine reverses drug resistance in isoniazid and ethambutol dual drug-resistant Mycobacterium tuberculosis clinical isolates
Open Access
- 25 March 2015
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 15 (1) , 153
Abstract
Tetrandrine is a natural chemical product purified from fourstamen stephania root which recently has been shown to act similarly as synthesized drug efflux pump inhibitor verapamil. The aim of the study is to examine whether tetrandrine could potentiate anti-tubercular drugs to which Mycobacterium tuberculosis (MTB) has turned resistant via efflux mechanisms. We screened 200 MTB clinical isolates using drug sensitivity test to look for those who have turned resistant to the drugs most probably due to efflux mechanisms. We found 29 isoniazid (INH) and ethambutol (EMB) - dual resistant (IEDR) strains. Then we tested if treatment with tetrandrine or verapamil could reverse drug resistance to INH and/or EMB in IEDR isolates. There is a parallel resistance among EMB- and INH-resistant strains in the tested clinical isolates. Among INH-resistant strains, 65% was also EMB-resistant. This suggests an involvement of efflux mechanisms which can lead to dual drug resistance in IEDR clinical isolates. Similar to a synthesized efflux pump inhibitor verapamil, tetrandrine treatment together with INH or EMB brought down the MICs from the clinical level of drug resistance to the sensitive range of both drugs. The effective rate reached 82% among IEDR clinical isolates. Combinational application of tetrandrine with INH or EMB increased drug efficacy. Drugs like tetrandrine may help to reduce drug dosage thus alleviate side effects.Keywords
This publication has 28 references indexed in Scilit:
- National Survey of Drug-Resistant Tuberculosis in ChinaNew England Journal of Medicine, 2012
- Efflux Pumps of Mycobacterium tuberculosis Play a Significant Role in Antituberculosis Activity of Potential Drug CandidatesAntimicrobial Agents and Chemotherapy, 2012
- Drug-Resistant Tuberculosis in Zhejiang Province, China, 1999–2008Emerging Infectious Diseases, 2012
- Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux MechanismCell, 2011
- Efflux‐Pump–Derived Multiple Drug Resistance to Ethambutol Monotherapy inMycobacterium tuberculosisand the Pharmacokinetics and Pharmacodynamics of EthambutolThe Journal of Infectious Diseases, 2010
- Molecular Epidemiology of Tuberculosis: Current InsightsClinical Microbiology Reviews, 2006
- Multidrug-resistance efflux pumps ? not just for resistanceNature Reviews Microbiology, 2006
- Application of the resazurin microtitre assay for detection of multidrug resistance in Mycobacterium tuberculosis in AlgiersJournal of Medical Microbiology, 2006
- Structural Basis of Multiple Drug-Binding Capacity of the AcrB Multidrug Efflux PumpScience, 2003
- Multidrug transporters from bacteria to man: similarities in structure and functionSeminars in Cancer Biology, 1997